Selection of hyperfunctional siRNAs with improved potency and specificity - Wikidata - awgldk - TriplyDB

Selection of hyperfunctional siRNAs with improved potency and specificity

Selection of hyperfunctional siRNAs with improved potency and specificity

http://www.wikidata.org/entity/Q39784931

about

siRNA Versus miRNA as Therapeutics for Gene Silencing Preclinical and clinical development of siRNA-based therapeutics Progress toward in vivo use of siRNAs-II Design and evaluation of genome-wide libraries for RNA interference screens Predicting siRNA potency with random forests and support vector machines A protein network-guided screen for cell cycle regulators in Drosophila.siSPOTR: a tool for designing highly specific and potent siRNAs for human and mouse.Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.An arrayed RNA interference genome-wide screen identifies candidate genes involved in the MicroRNA 21 biogenesis pathway Discovery of a dicer-independent, cell-type dependent alternate targeting sequence generator: implications in gene silencing & pooled RNAi screens.Vigilance and validation: Keys to success in RNAi screening.Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system.Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides.Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis.Rational design of microRNA-siRNA chimeras for multifunctional target suppression.Small interfering ribonucleic acid design strategies for effective targeting and gene silencing.E-RNAi: a web application for the multi-species design of RNAi reagents--2010 update High-Throughput Silencing Using the CRISPR-Cas9 System: A Review of the Benefits and Challenges.Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma.Calreticulin is required for calcium homeostasis and proper pollen tube tip growth in Petunia.Development of a siRNA and shRNA screening system based on a kinase fusion protein.Biologically inhibitory effects of VEGF siRNA on endometrial carcinoma cells.Z' factor including siRNA design quality parameter in RNAi screening experiments.Polymeric Delivery of siRNA against Integrin-β1 (CD29) to Reduce Attachment and Migration of Breast Cancer Cells.A delayed proinflammatory response of human preadipocytes to PCB126 is dependent on the aryl hydrocarbon receptor.

P2860

Q26786876-B46B4688-CEC7-45CA-B750-DBCF436BC1E9 Q28085290-F9A61E3F-7EDC-46B5-AD49-DBEBE039EA5F Q28255877-CF2E67A7-9354-48E9-BEA1-C750D2F4E253 Q33605316-61AD344B-A1CA-42B7-A070-2424353B0209 Q33766604-CBC2F5AC-B6F1-45F7-A860-E18976D21254 Q33891584-515926FC-C6F9-4BEC-B591-55FF2C0FEF2A Q34401341-D90AA4C8-F461-4AE9-A373-E3B9D3B4500E Q34477489-6FA9EAA3-84EA-42C4-BD2E-1115A8BC4F22 Q34478217-B27F1DB1-FD25-4A7B-9AAD-81713B6CD8CB Q35200048-FDF01AF1-FB49-4232-93D9-B018D6B6C641 Q35836004-8C20C8D3-48FC-445A-A366-152ABDF0C744 Q36174842-56D310C8-C448-4258-AA68-3DF34605C1CE Q36238544-18A4FBA2-DE1F-4A86-A34A-5FEFC47448B0 Q36532644-1A539D86-ED81-46CE-874F-4E9E47DC79F9 Q37138610-1D1EDB7F-0A5E-4702-9881-2FF9CAD9E240 Q37448777-9A955762-F2D2-4978-A499-5C55E7EEE264 Q38014586-40AE500E-1870-4BA3-81F2-2083CB20BB88 Q38373756-15C4A155-CD9E-4AFB-BA64-921C3E642CDD Q38498286-C8C070AB-A388-4250-9FFA-B3824AA26260 Q38930757-45F6A591-4A1E-4486-86AA-E2636F81A70E Q39025789-D42C69B6-7909-4C8F-B755-CFCAD4B2A2EB Q39357612-B2B0C0CC-E2CC-48F9-90A1-AE7511D15D49 Q39447186-4749AAAC-779D-4FB0-9DDA-E5AE60241509 Q43488071-51C10A32-315D-4AE1-92A0-90E2835BD82C Q51017795-59E85D98-EA2E-4B70-9A04-B0074256A951 Q52682873-4A57082B-F952-4AC5-AF44-A249745AB3B7

P2860

Selection of hyperfunctional siRNAs with improved potency and specificity

http://www.wikidata.org/entity/Q39784931

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Selection of hyperfunctional siRNAs with improved potency and specificity

@en

Selection of hyperfunctional siRNAs with improved potency and specificity.

@nl

type

label

Selection of hyperfunctional siRNAs with improved potency and specificity

@en

Selection of hyperfunctional siRNAs with improved potency and specificity.

@nl

prefLabel

Selection of hyperfunctional siRNAs with improved potency and specificity

@en

Selection of hyperfunctional siRNAs with improved potency and specificity.

@nl

P1433

Q39784931-8692E8C0-C4A0-44C7-B596-CA1CDC52B3BF

P1476

Q39784931-8378D67B-E490-4014-A3B4-1ABD0E778B57

P2093

Q39784931-296E4116-93CE-4AFB-B9DF-25E794AF0591

Q39784931-650B7D6B-575F-476B-8EDE-3B82507854AC

Q39784931-6FAD41F6-7F75-41E2-8C80-25BE24FBB7AF

Q39784931-75AB3823-E191-400C-9CCE-44F34C09E562

Q39784931-E3A424D3-A4B5-4F0B-B423-3D2B69D23A9A

Q39784931-ECCF13E7-B761-436D-8E7A-AF450275CA7C

P2860

Q39784931-000EB95D-C573-4227-8CA1-38F8547892EC

Q39784931-086F11A2-7B97-42AD-BAF8-C3A20B8AD988

Q39784931-0A02A596-08D6-454C-A5F9-E3CEAEF186EF

Q39784931-0AB3C984-F96E-4E7D-ACF6-5B310CE960A7

Q39784931-0B6422C8-2089-4330-B3E9-2A8195679A59

Q39784931-1B189A6C-2854-4347-9265-3BDDC76292AD

Q39784931-1BC92E0D-ABD0-4460-AB46-5ACEC5B86598

Q39784931-1F041475-5D39-4095-AA3D-7AE1BC6D1C5F

Q39784931-2483CFC5-4F69-4536-9768-9117CDAC3C8E

Q39784931-24E5A368-3AF2-40DA-9019-F3E5C4925FE7

P304

Q39784931-7CE46989-C0D9-4C8E-B7D1-6F9D3F7ADBC6

P31

Q39784931-F6A799D9-2FBD-4705-A15C-C47E043DDE39

P356

Q39784931-ABDB718E-8AEC-4209-9347-665CDED2B463

P407

Q39784931-87164710-87BD-450E-8C35-3EAC0BB13FAE

P433

Q39784931-880F26FD-494C-4B44-9BA4-97CFAAD1FAD5

P478

Q39784931-876A3270-0A28-46C4-80C7-E8B27F71F740

P577

Q39784931-9892B1DD-A51B-4F32-B6A5-D21E94EF144E

P5875

Q39784931-B0907049-18FF-420A-A66D-04A3A54F2AA9

P698

Q39784931-44F41D7A-6954-496B-8D2B-D7D765F5A2CF

P932

Q39784931-FA63AFF9-BFAF-4302-8B77-C2D5E213A02F

P356

P1433

Nucleic Acids Research

P1476

Selection of hyperfunctional siRNAs with improved potency and specificity

@en

P2093

Lesslie Beauchamp

http://www.w3.org/2001/XMLSchema#string

Rajeev K Varma

http://www.w3.org/2001/XMLSchema#string

Susan Magdaleno

http://www.w3.org/2001/XMLSchema#string

Timothy J Sendera

http://www.w3.org/2001/XMLSchema#string

Xiaohui Wang

http://www.w3.org/2001/XMLSchema#string

Xiaowei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP

The contributions of dsRNA structure to Dicer specificity and efficiency.

NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins

siRNA target site secondary structure predictions using local stable substructures

siRNA-mediated off-target gene silencing triggered by a 7 nt complementation

Asymmetry in the assembly of the RNAi enzyme complex

Functional siRNAs and miRNAs exhibit strand bias

RNA interference

Vienna RNA secondary structure server

Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain

P304

e152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/GKP864

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38027476

http://www.w3.org/2001/XMLSchema#string

P698

19846596

http://www.w3.org/2001/XMLSchema#string

P932

2794195

http://www.w3.org/2001/XMLSchema#string